Cargando…

288 Minimal Change Disease Relapse After SARS-CoV-2 Booster Vaccine

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935026/ http://dx.doi.org/10.1053/j.ajkd.2022.01.293

Ejemplares similares

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
por: Özkan, Gülsüm, et al.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination
por: Yun Lim, So, et al.
Publicado: (2023)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

Minimal change disease following vaccination for SARS-CoV-2
por: Mancianti, Nicoletta, et al.
Publicado: (2021)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

The societal value of SARS-CoV-2 booster vaccination in Indonesia
por: Johnson, Rob, et al.
Publicado: (2023)

Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study
por: Pinotti, Francesco, et al.
Publicado: (2020)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18
por: Alhosaini, Mohamad Nour
Publicado: (2022)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 omicron after BBIBP-CorV and ZF2001 booster vaccination
por: Zhang, Yuwei, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022)

Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients
por: Urra, J.M., et al.
Publicado: (2023)

Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting
por: Teti, C., et al.
Publicado: (2022)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy
por: Dick, Aharon, et al.
Publicado: (2022)

Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
por: Cheng, Hoi Lok, et al.
Publicado: (2022)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies
por: Rick, Anne-Marie, et al.
Publicado: (2023)

Severe breakthrough COVID-19 after SARS-CoV-2 booster vaccination in an MS patient on ocrelizumab
por: van Kempen, Zoé L.E., et al.
Publicado: (2022)

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
por: Piñana, José Luis, et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
por: Salvagno, G.L., et al.
Publicado: (2022)

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
por: Naranbhai, Vivek, et al.
Publicado: (2022)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
por: Balkan, İlker İnanc, et al.
Publicado: (2022)

The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2
por: Kraay, A. N. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mki63iritf0h06n3vmo71f8gsm